Precautions for breast ultrasound examination following COVID-19 vaccination
Open Access
- 10 October 2021
- journal article
- research article
- Published by Korean Medical Association (KAMJE) in Journal of the Korean Medical Association
- Vol. 64 (10), 671-677
- https://doi.org/10.5124/jkma.2021.64.10.671
Abstract
Background: Coronavirus disease 2019 (COVID-19) vaccine-induced lymphadenopathy is a critical side effect that should be a concern to clinicians, patients, radiologists, and oncologists. Vaccine-induced lymphadenopathy causes a diagnostic dilemma, especially for breast radiologists who examine both axillary regions during breast ultrasound examinations. Appropriate imaging guidelines are needed to manage vaccine-induced lymphadenopathy for patients undergoing screening examinations or symptomatic patients, including cancer patients. Current Concepts: For patients with axillary lymphadenopathy in the setting of recent ipsilateral vaccination, clinical follow-up is recommended. In other scenarios, short-term follow-up axillary ultrasound examinations are recommended if the clinical concerns persist for more than 6 weeks after vaccination. To mitigate the diagnostic dilemma of vaccine-induced lymphadenopathy, patients should schedule screening imaging examinations before the first vaccination or at least six weeks following the second vaccination. For clinicians and radiologists, documenting the patients' vaccination status is critical to decreasing unnecessary follow-up imaging, biopsies, and patient's anxiety. Discussion and Conclusion: Our proposal can help reduce patient anxiety, provider burden, and costs of unnecessary evaluation of enlarged lymph nodes in the setting of recent COVID-19 vaccination. Further, it can avoid delays in vaccination and breast cancer screening during the COVID-19 pandemic.Keywords
This publication has 23 references indexed in Scilit:
- Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studiesEuropean Journal of Cancer, 2020
- Critical review of axillary recurrence in early breast cancerCritical Reviews in Oncology/Hematology, 2018
- Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human PapillomavirusesClinical Nuclear Medicine, 2017
- Generalized lymph node activation after Influenza vaccination on 18F FDG-PET/CT imaging, an important pitfall in PET interpretation2017
- Axillary lymph node accumulation on FDG-PET/CT after influenza vaccinationAnnals of Nuclear Medicine, 2012
- Incidence and Intensity of F-18 FDG Uptake After Vaccination With H1N1 VaccineClinical Nuclear Medicine, 2011
- Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccinationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- False-Positive Hypermetabolic Lesions on Post-Treatment PET-CT after Influenza VaccinationThe Korean Journal of Internal Medicine, 2011
- FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1)European Radiology, 2010
- False-Positive Axillary Lymph Node on FDG-PET/CT Scan Resulting From ImmunizationClinical Nuclear Medicine, 2006